Yves Gourmelin
Overview
Explore the profile of Yves Gourmelin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
133
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samama M, Contant G, Spiro T, Perzborn E, Le Flem L, Guinet C, et al.
Thromb J
. 2013 Jul;
11(1):11.
PMID: 23822763
Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of which greatly decreases...
2.
Samama M, Contant G, Spiro T, Perzborn E, Le Flem L, Guinet C, et al.
Clin Appl Thromb Hemost
. 2012 Mar;
18(2):150-8.
PMID: 22387577
This study evaluated the prothrombin time (PT) assay for the measurement of plasma concentrations of rivaroxaban using calibrators and controls. The intra- and interlaboratory precision of the measurement was investigated...
3.
Samama M, Contant G, Spiro T, Perzborn E, Guinet C, Gourmelin Y, et al.
Thromb Haemost
. 2011 Dec;
107(2):379-87.
PMID: 22187012
Rivaroxaban is an oral, direct factor Xa inhibitor. Routine coagulation monitoring is not required, but a quantitative determination of rivaroxaban concentrations might be useful in some clinical circumstances. This multicentre...